New Zealand markets closed

Sartorius Stedim Biotech S.A. (SDMHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
220.00+12.25 (+5.90%)
At close: 10:15AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.38B
Enterprise value 25.21B
Trailing P/E 60.81
Forward P/E 34.36
PEG ratio (5-yr expected) 1.36
Price/sales (ttm)6.78
Price/book (mrq)7.54
Enterprise value/revenue 9.08
Enterprise value/EBITDA 33.36

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3-20.12%
S&P500 52-week change 325.59%
52-week high 3321.11
52-week low 3175.12
50-day moving average 3261.39
200-day moving average 3250.87

Share statistics

Avg vol (3-month) 3419
Avg vol (10-day) 31.96k
Shares outstanding 597.3M
Implied shares outstanding 699.15M
Float 829.29M
% held by insiders 169.71%
% held by institutions 113.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.75
Forward annual dividend yield 40.34%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 40.50
Payout ratio 442.86%
Dividend date 3N/A
Ex-dividend date 402 Apr 2024
Last split factor 26:1
Last split date 306 May 2016

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.38%
Operating margin (ttm)16.49%

Management effectiveness

Return on assets (ttm)3.92%
Return on equity (ttm)8.15%

Income statement

Revenue (ttm)2.72B
Revenue per share (ttm)29.09
Quarterly revenue growth (yoy)-8.20%
Gross profit (ttm)N/A
EBITDA 635.8M
Net income avi to common (ttm)254.7M
Diluted EPS (ttm)3.61
Quarterly earnings growth (yoy)-49.50%

Balance sheet

Total cash (mrq)695.1M
Total cash per share (mrq)7.19
Total debt (mrq)3.19B
Total debt/equity (mrq)82.46%
Current ratio (mrq)2.13
Book value per share (mrq)39.62

Cash flow statement

Operating cash flow (ttm)636.2M
Levered free cash flow (ttm)27.25M